Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Farmers Insurance
Medtronic
Daiichi Sankyo
US Army
Harvard Business School
Teva
Citi
Mallinckrodt

Generated: July 15, 2018

DrugPatentWatch Database Preview

Insulin susp isophane beef - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for insulin susp isophane beef and what is the scope of insulin susp isophane beef patent protection?

Insulin susp isophane beef
is the generic ingredient in two branded drugs marketed by Novo Nordisk Inc and Lilly, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-nine drug master file entries for insulin susp isophane beef.
Summary for insulin susp isophane beef
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 39
Clinical Trials: 7
DailyMed Link:insulin susp isophane beef at DailyMed

US Patents and Regulatory Information for insulin susp isophane beef

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly NPH ILETIN I (BEEF-PORK) insulin susp isophane beef/pork INJECTABLE;INJECTION 017936-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novo Nordisk Inc NPH INSULIN insulin susp isophane beef INJECTABLE;INJECTION 017929-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly NPH ILETIN I (BEEF-PORK) insulin susp isophane beef/pork INJECTABLE;INJECTION 017936-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novo Nordisk Inc NPH INSULIN insulin susp isophane beef INJECTABLE;INJECTION 017929-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Healthtrust
Deloitte
UBS
Moodys
Daiichi Sankyo
McKesson
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.